The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Soleno Therapeutics, Inc. (NASDAQ: SLNO) focused on whether Soleno and ...

Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that its Board of Directors has ...

As of September 30, 2025, Tonix had $190.1 million in cash and cash equivalents, compared with $98.8 million as of December 31, 2024. Net cash used in operations was approximately $60.2 million for ...

THE COMPANY: On March 26, 2025, Soleno announced that the U.S. Food and Drug Administration had approved VYKAT XR (diazoxide choline) extended-release tablets for the treatment of hyperphagia in ...

Furthermore, Scorpion alleged that Soleno's "launch metrics are hocus-pocus," claiming that the company was highly dependent on a "controversial physician" in Gainesville, Florida, who was the lead ...

Company will host a webcast at 10am ET on November 6, 2025, to discuss its Phase 2a study to assess efficacy, safety and ...

For parents whose children are undergoing growth hormone therapy, the focus might be on height and physical development, but ...

Rhythm Pharmaceuticals will host a live conference call and webcast at 8:00 a.m. ET today to review its third quarter 2025 financial results and recent business activities. Participants may register ...

Katie Price shared a photograph of her son Harvey in hospital as she kept fans updated after he lost 1.5 stone with weight ...

When Big Pharma ties its corporate social responsibility initiatives to patients' needs, too often it veers into theater.

A child's healthy growth is a complex interplay of genetics, hormones and nutrition. Experts emphasize that factors like ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.